First Header Logo Second Header Logo

Connection

Steven Feldman to Rosacea

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Rosacea.
Steven Feldman
Connection Strength
16.143
Rosacea
  1. Okwundu N, Cline A, Feldman SR. Difference in vasoconstrictors: oxymetazoline vs. brimonidine. J Dermatolog Treat. 2021 Mar; 32(2):137-143.
    View in: PubMed
    Score: 0.631
  2. Tjahjono LA, Cline A, Huang WW, Fleischer AB, Feldman SR. Rosacea: Relative risk versus absolute risk of malignant comorbidities. J Am Acad Dermatol. 2019 08; 81(2):623-624.
    View in: PubMed
    Score: 0.606
  3. Alinia H, Cardwell LA, Tuchayi SM, Nadkarni A, Bahrami N, Richardson IM, Huang KE, Feldman SR. Screening for depression in rosacea patients. Cutis. 2018 Jul; 102(1):36-38.
    View in: PubMed
    Score: 0.584
  4. McGregor SP, Alinia H, Snyder A, Tuchayi SM, Fleischer A, Feldman SR. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatol Clin. 2018 Apr; 36(2):135-150.
    View in: PubMed
    Score: 0.563
  5. Turbeville JG, Alinia H, Tuchayi SM, Bahrami N, Cardwell LA, Awosika O, Richardson I, Huang KE, Feldman SR. Patient Costs Associated with Rosacea. Dermatol Clin. 2018 Apr; 36(2):167-170.
    View in: PubMed
    Score: 0.563
  6. Cardwell LA, Nyckowski T, Uwakwe LN, Feldman SR. Coping Mechanisms and Resources for Patients Suffering from Rosacea. Dermatol Clin. 2018 Apr; 36(2):171-174.
    View in: PubMed
    Score: 0.563
  7. Alinia H, Tuchayi SM, Patel NU, Patel N, Awosika O, Bahrami N, Cardwell LA, Richardson I, Huang KE, Feldman SR. Rosacea Triggers: Alcohol and Smoking. Dermatol Clin. 2018 Apr; 36(2):123-126.
    View in: PubMed
    Score: 0.563
  8. Alinia H, Tuchayi SM, James SM, Cardwell LA, Nanda S, Bahrami N, Awosika O, Richardson I, Huang KE, Feldman SR. Measurement of Disease Severity in a Population of Rosacea Patients. Dermatol Clin. 2018 Apr; 36(2):97-102.
    View in: PubMed
    Score: 0.563
  9. Cline A, McGregor SP, Feldman SR. Medical Management of Facial Redness in Rosacea. Dermatol Clin. 2018 Apr; 36(2):151-159.
    View in: PubMed
    Score: 0.563
  10. Moradi Tuchayi S, Alinia H, Lan L, Awosika O, Cline A, Cardwell LA, Hopkinson D, Richardson I, Huang KE, Feldman SR. Validity and Reliability of a Rosacea Self-Assessment Tool. Dermatol Clin. 2018 Apr; 36(2):93-96.
    View in: PubMed
    Score: 0.561
  11. Feldman SR, Cardwell LA, Taylor SL. Complexities of Rosacea. Dermatol Clin. 2018 Apr; 36(2):xiii.
    View in: PubMed
    Score: 0.559
  12. Patel NU, Shukla S, Zaki J, Feldman SR. Oxymetazoline hydrochloride cream for facial erythema associated with rosacea. Expert Rev Clin Pharmacol. 2017 Oct; 10(10):1049-1054.
    View in: PubMed
    Score: 0.551
  13. Hill D, Feldman SR. Cost of diagnosing psoriasis and rosacea for dermatologists versus primary care physicians. Cutis. 2017 Feb; 99(2):134-136.
    View in: PubMed
    Score: 0.530
  14. James SM, Hill DE, Feldman SR. Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study. Dermatol Online J. 2016 Oct 15; 22(10).
    View in: PubMed
    Score: 0.519
  15. James SM, Hill DE, Feldman SR. Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study. Dermatol Online J. 2016 Sep 15; 22(9).
    View in: PubMed
    Score: 0.516
  16. Wehausen B, Hill DE, Feldman SR. Most people with psoriasis or rosacea are not being treated: a large population study. Dermatol Online J. 2016 Jul 15; 22(7).
    View in: PubMed
    Score: 0.510
  17. Alinia H, Moradi Tuchayi S, Farhangian ME, Huang KE, Taylor SL, Kuo S, Richardson I, Feldman SR. Rosacea patients seeking advice: Qualitative analysis of patients' posts on a rosacea support forum. J Dermatolog Treat. 2016; 27(2):99-102.
    View in: PubMed
    Score: 0.491
  18. Hopkinson D, Moradi Tuchayi S, Alinia H, Feldman SR. Assessment of rosacea severity: A review of evaluation methods used in clinical trials. J Am Acad Dermatol. 2015 Jul; 73(1):138-143.e4.
    View in: PubMed
    Score: 0.465
  19. Moustafa F, Hopkinson D, Huang KE, Feldman S. Prevalence of rosacea in community settings. J Cutan Med Surg. 2015 Mar-Apr; 19(2):149-52.
    View in: PubMed
    Score: 0.464
  20. Kuo S, Huang KE, Davis SA, Feldman SR. The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis. 2015 Jan; 95(1):37-43.
    View in: PubMed
    Score: 0.458
  21. McGinley M, Alinia H, Kuo S, Huang KE, Feldman SR. Patient perspectives on low level light therapy and laser therapies for rosacea-associated persistent facial redness. Dermatol Online J. 2014 Dec 13; 21(2).
    View in: PubMed
    Score: 0.457
  22. Al-Dabagh A, Davis SA, McMichael AJ, Feldman SR. Rosacea in skin of color: not a rare diagnosis. Dermatol Online J. 2014 Oct 15; 20(10).
    View in: PubMed
    Score: 0.452
  23. Moustafa FA, Sandoval LF, Feldman SR. Rosacea: new and emerging treatments. Drugs. 2014 Sep; 74(13):1457-65.
    View in: PubMed
    Score: 0.448
  24. Davis SA, Feldman SR. Patterns of ambulatory care usage and leading treatments for rosacea. J Dermatolog Treat. 2014 Aug; 25(4):275-7.
    View in: PubMed
    Score: 0.445
  25. Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014 Nov; 71(5):973-80.
    View in: PubMed
    Score: 0.443
  26. Feldman SR, Huang WW, Huynh TT. Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease. J Manag Care Spec Pharm. 2014 Jun; 20(6):623-9.
    View in: PubMed
    Score: 0.440
  27. Cresce ND, Davis SA, Huang WW, Feldman SR. The quality of life impact of acne and rosacea compared to other major medical conditions. J Drugs Dermatol. 2014 Jun; 13(6):692-7.
    View in: PubMed
    Score: 0.440
  28. Lin HC, Alamdari HS, Huang KE, Gustafson CJ, Davis SA, Balkrishnan R, Feldman SR. Prevalence of psoriasis and rosacea comorbidities in the outpatient setting. J Cutan Med Surg. 2013 Sep-Oct; 17(5):295-8.
    View in: PubMed
    Score: 0.418
  29. Alikhan A, Kurek L, Feldman SR. The role of tetracyclines in rosacea. Am J Clin Dermatol. 2010; 11(2):79-87.
    View in: PubMed
    Score: 0.324
  30. Thomas K, Yelverton CB, Yentzer BA, Balkrishnan R, Fleischer AB, Feldman SR. The cost-effectiveness of rosacea treatments. J Dermatolog Treat. 2009; 20(2):72-5.
    View in: PubMed
    Score: 0.302
  31. Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB, Feldman SR. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol. 2007 May; 6(5):495-8.
    View in: PubMed
    Score: 0.269
  32. Kirkland CR, Yelverton CB, Fleischer AB, Camacho FT, Feldman SR. Gel vehicles are not inherently more irritating than creams. J Drugs Dermatol. 2006 Mar; 5(3):269-72.
    View in: PubMed
    Score: 0.248
  33. Feaster B, Cline A, Feldman SR, Taylor S. Clinical effectiveness of novel rosacea therapies. Curr Opin Pharmacol. 2019 06; 46:14-18.
    View in: PubMed
    Score: 0.152
  34. Sahni DR, Feldman SR, Taylor SL. Ivermectin 1% (CD5024) for the treatment of rosacea. Expert Opin Pharmacother. 2018 Apr; 19(5):511-516.
    View in: PubMed
    Score: 0.143
  35. Taieb A, Stein Gold L, Feldman SR, Dansk V, Bertranou E. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States. J Manag Care Spec Pharm. 2016 Jun; 22(6):654-65.
    View in: PubMed
    Score: 0.126
  36. Glenn C, Feldman SR. Letter: Tetracycline-induced hepatotoxicity. Dermatol Online J. 2011 Dec 15; 17(12):14.
    View in: PubMed
    Score: 0.093
  37. Jayawant SS, Feldman SR, Camacho FT, Yentzer B, Balkrishnan R. Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. J Dermatolog Treat. 2008; 19(5):267-73.
    View in: PubMed
    Score: 0.071
  38. Sugarman JH, Fleischer AB, Feldman SR. Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol. 2002 Aug; 47(2):217-23.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.